clindamycin hydrochloride

Generic: clindamycin hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clindamycin hydrochloride
Generic Name clindamycin hydrochloride
Labeler a-s medication solutions
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

clindamycin hydrochloride 300 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-4575
Product ID 50090-4575_aa5114bb-9acc-4fe5-9bc5-b9205435122f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207402
Listing Expiration 2026-12-31
Marketing Start 2019-01-07

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] lincosamide antibacterial [epc] lincosamides [cs] neuromuscular blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500904575
Hyphenated Format 50090-4575

Supplemental Identifiers

RxCUI
284215
UNII
T20OQ1YN1W

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clindamycin hydrochloride (source: ndc)
Generic Name clindamycin hydrochloride (source: ndc)
Application Number ANDA207402 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (50090-4575-0)
  • 45 CAPSULE in 1 BOTTLE (50090-4575-1)
  • 16 CAPSULE in 1 BOTTLE (50090-4575-2)
  • 40 CAPSULE in 1 BOTTLE (50090-4575-3)
  • 20 CAPSULE in 1 BOTTLE (50090-4575-4)
source: ndc

Packages (5)

50090-4575-0 30 CAPSULE in 1 BOTTLE (50090-4575-0) 50090-4575-1 45 CAPSULE in 1 BOTTLE (50090-4575-1) 50090-4575-2 16 CAPSULE in 1 BOTTLE (50090-4575-2) 50090-4575-3 40 CAPSULE in 1 BOTTLE (50090-4575-3) 50090-4575-4 20 CAPSULE in 1 BOTTLE (50090-4575-4)

Ingredients (1)

clindamycin hydrochloride (300 mg/1)

Linked Drug Pages (1)

CLINDAMYCIN HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "aa5114bb-9acc-4fe5-9bc5-b9205435122f", "openfda": {"unii": ["T20OQ1YN1W"], "rxcui": ["284215"], "spl_set_id": ["07f5d841-9c58-4dd1-b0bc-e12553931c8e"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-4575-0)", "package_ndc": "50090-4575-0", "marketing_start_date": "20191004"}, {"sample": false, "description": "45 CAPSULE in 1 BOTTLE (50090-4575-1)", "package_ndc": "50090-4575-1", "marketing_start_date": "20191004"}, {"sample": false, "description": "16 CAPSULE in 1 BOTTLE (50090-4575-2)", "package_ndc": "50090-4575-2", "marketing_start_date": "20191004"}, {"sample": false, "description": "40 CAPSULE in 1 BOTTLE (50090-4575-3)", "package_ndc": "50090-4575-3", "marketing_start_date": "20191004"}, {"sample": false, "description": "20 CAPSULE in 1 BOTTLE (50090-4575-4)", "package_ndc": "50090-4575-4", "marketing_start_date": "20191004"}], "brand_name": "CLINDAMYCIN HYDROCHLORIDE", "product_id": "50090-4575_aa5114bb-9acc-4fe5-9bc5-b9205435122f", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Lincosamide Antibacterial [EPC]", "Lincosamides [CS]", "Neuromuscular Blockade [PE]"], "product_ndc": "50090-4575", "generic_name": "Clindamycin hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CLINDAMYCIN HYDROCHLORIDE", "active_ingredients": [{"name": "CLINDAMYCIN HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA207402", "marketing_category": "ANDA", "marketing_start_date": "20190107", "listing_expiration_date": "20261231"}